Evotec
Generated by Meeveem AI
"Drug discovery, development and biologics manufacturing"
About Evotec
Evotec discovers and develops medicines across small molecules, biologics and cell therapies. Its platforms include Molecular Patient Databases and iPSC-based disease modelling, supporting pharmaceutical, biotech, academic and non-profit partners. Through Just - Evotec Biologics, the group also develops and manufactures biotherapeutics.
Founded in 1993 and headquartered in Hamburg, Evotec works across Europe and the United States, with UK sites in Abingdon and Alderley Park. It reports working with all Top 20 pharma companies and over 800 biotechs through standalone services, integrated research programmes and strategic partnerships that can share risk and intellectual property. The group employed an average of 4,379 people during the first nine months of 2026.
Working across disciplines
Evotec describes collaboration across borders and scientific disciplines, supported by communication tools, digital platforms, laboratories and workspaces. Its careers information covers opportunities in research and development, production and business development, alongside the functions that support the business. Working arrangements and opportunities for international assignments depend on the role and local requirements.
4379
Team Members
1993
Founded
Contract Research
Sector
On-Site
Work Environment